Most-Downgraded StocksMost-DowngradedNASDAQ:DCGO DocGo (DCGO) Stock Price, News & Analysis → Protect Your Bank Account Before It’s Too Late (From Weiss Ratings) (Ad) Free DCGO Stock Alerts $3.05 +0.11 (+3.74%) (As of 05/24/2024 08:49 PM ET) Add Compare Share Share Today's Range$2.92▼$3.0650-Day Range$2.94▼$4.0952-Week Range$2.78▼$10.82Volume649,100 shsAverage Volume1.40 million shsMarket Capitalization$309.79 millionP/E Ratio15.25Dividend YieldN/APrice Target$7.75 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get DocGo alerts: Email Address DocGo MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside154.1% Upside$7.75 Price TargetShort InterestHealthy10.25% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.82Based on 2 Articles This WeekInsider TradingAcquiring Shares$146,150 Bought Last QuarterProj. Earnings Growth-50.00%From $0.24 to $0.12 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.64 out of 5 starsMedical Sector173rd out of 923 stocksHealth Services Industry2nd out of 11 stocks 4.5 Analyst's Opinion Consensus RatingDocGo has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageDocGo has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about DocGo's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted10.25% of the float of DocGo has been sold short.Short Interest Ratio / Days to CoverDocGo has a short interest ratio ("days to cover") of 8.5.Change versus previous monthShort interest in DocGo has recently decreased by 6.26%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldDocGo does not currently pay a dividend.Dividend GrowthDocGo does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for DCGO. Previous Next 2.1 News and Social Media Coverage News SentimentDocGo has a news sentiment score of 0.82. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for DocGo this week, compared to 4 articles on an average week.Search Interest1 people have searched for DCGO on MarketBeat in the last 30 days. MarketBeat FollowsOnly 4 people have added DocGo to their MarketBeat watchlist in the last 30 days. This is a decrease of -60% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, DocGo insiders have bought more of their company's stock than they have sold. Specifically, they have bought $146,150.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 2.70% of the stock of DocGo is held by insiders.Percentage Held by Institutions56.44% of the stock of DocGo is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about DocGo's insider trading history. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for DocGo are expected to decrease by -50.00% in the coming year, from $0.24 to $0.12 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of DocGo is 15.25, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 127.26.Price to Earnings Ratio vs. SectorThe P/E ratio of DocGo is 15.25, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 104.37.Price to Earnings Growth RatioDocGo has a PEG Ratio of 1.52. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioDocGo has a P/B Ratio of 1.04. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about DocGo's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Weiss RatingsProtect Your Bank Account Before It’s Too LateFor months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …Stop right now and do these 3 things to protect yourself About DocGo Stock (NASDAQ:DCGO)DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.Read More DCGO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DCGO Stock News HeadlinesMay 14, 2024 | insidertrades.comDocGo Inc. (NASDAQ:DCGO) General Counsel Purchases $31,300.00 in StockMay 21, 2024 | businesswire.comDocGo Announces Upcoming Participation at Stifel Cross Sector Insight ConferenceMay 12, 2024 | finance.yahoo.comDocGo Inc. (NASDAQ:DCGO) Q1 2024 Earnings Call TranscriptMay 10, 2024 | finance.yahoo.comDocGo Inc (DCGO) Surpasses Analyst Revenue Forecasts with Strong Q1 2024 PerformanceMay 10, 2024 | finance.yahoo.comDocGo First Quarter 2024 Earnings: EPS Beats ExpectationsMay 9, 2024 | markets.businessinsider.comBuy Rating on DocGo: Strong Growth Potential and Financial Health Despite Revenue Base ChangesMay 9, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: DocGo (DCGO), Avadel Pharmaceuticals (AVDL)May 9, 2024 | finance.yahoo.comDocGo Inc (DCGO) Q1 2024 Earnings Call Transcript Highlights: Soaring Revenues and Strategic ...May 8, 2024 | investorplace.comDCGO Stock Earnings: DocGo Beats EPS, Beats Revenue for Q1 2024May 8, 2024 | finance.yahoo.comDocGo Announces Strong First Quarter 2024 ResultsMay 8, 2024 | finance.yahoo.comWith 52% ownership of the shares, DocGo Inc. (NASDAQ:DCGO) is heavily dominated by institutional ownersMay 1, 2024 | nasdaq.comDocGo Inc. Common Stock (DCGO)April 30, 2024 | markets.businessinsider.comEvaluating DocGo: Insights From 8 Financial AnalystsApril 22, 2024 | businesswire.comDocGo to Announce First Quarter 2024 Results on Wednesday, May 8, 2024April 17, 2024 | msn.comDocGo (DCGO) Price Target Decreased by 7.98% to 10.08April 12, 2024 | investing.comStifel cuts DocGo stock target, maintains buy amid contract shiftApril 11, 2024 | markets.businessinsider.comPeeling Back The Layers: Exploring DocGo Through Analyst InsightsApril 10, 2024 | businesswire.comDocGo Signs Extension and Begins Planned Transition of Asylum Seeker Contract with New York City HPDApril 10, 2024 | msn.comDocGo slips as New York City moves to end migrant contractApril 2, 2024 | businesswire.comDocGo Becomes Official Partner of New York City Football ClubMarch 29, 2024 | businesswire.comDOCGO INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of DocGo Inc. - DCGOMarch 28, 2024 | finance.yahoo.comDeclining Stock and Decent Financials: Is The Market Wrong About DocGo Inc. (NASDAQ:DCGO)?March 20, 2024 | markets.businessinsider.comDocGo Inc. (DCGO) Investor Alert: Grabar Law Office Investigates Claims on Behalf Of DocGo InvestorsMarch 20, 2024 | investing.comDocGo CFO Norman Rosenberg buys $36.1k in company sharesMarch 20, 2024 | seekingalpha.comDocGo: Upside Remains Attractive After Share Price DeclineSee More Headlines Receive DCGO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DocGo and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/28/2024Today5/27/2024Next Earnings (Estimated)8/05/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Health services Sub-IndustryN/A Current SymbolNASDAQ:DCGO CUSIPN/A CIK1822359 Webwww.docgo.com Phone844-443-6246FaxN/AEmployees4,164Year FoundedN/APrice Target and Rating Average Stock Price Target$7.75 High Stock Price Target$16.00 Low Stock Price Target$5.00 Potential Upside/Downside+154.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)$0.20 Trailing P/E Ratio15.25 Forward P/E Ratio12.71 P/E Growth1.52Net Income$6.86 million Net Margins2.98% Pretax Margin5.41% Return on Equity6.20% Return on Assets4.14% Debt Debt-to-Equity RatioN/A Current Ratio2.09 Quick Ratio2.09 Sales & Book Value Annual Sales$703.37 million Price / Sales0.44 Cash Flow$0.21 per share Price / Cash Flow14.33 Book Value$3.10 per share Price / Book0.98Miscellaneous Outstanding Shares101,566,000Free Float87,570,000Market Cap$309.78 million OptionableOptionable Beta0.96 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Lee Bienstock (Age 39)CEO & Director Comp: $2.21MMr. Norman Rosenberg (Age 54)Treasurer & CFO Comp: $1.43MMr. Ely D. Tendler (Age 56)General Counsel, Secretary & Director Comp: $926.37kMr. Stephen Sugrue (Age 51)Chief Compliance Officer Comp: $864.35kMr. Andre Oberholzer CPA (Age 65)Executive Vice President of Strategy Comp: $1.48MMike ColeVice President of Investor RelationsMs. Rosemarie MilanoVice President of Human ResourcesMr. Aaron SeversChief Product OfficerMs. Vrenely MunozChief Revenue OfficerDr. James PowellChief Executive Officer of Clinical Practice GroupMore ExecutivesKey CompetitorsSharecareNASDAQ:SHCRQuantum-SiNASDAQ:QSIAgroFresh SolutionsNASDAQ:AGFSTalkspaceNASDAQ:TALKOrigin MaterialsNASDAQ:ORGNView All CompetitorsInsiders & InstitutionsKennedy Capital Management LLCSold 314,520 shares on 5/16/2024Ownership: 1.418%Janus Henderson Group PLCSold 12,216 shares on 5/16/2024Ownership: 0.332%Jacobs Levy Equity Management Inc.Bought 166,247 shares on 5/16/2024Ownership: 0.160%California State Teachers Retirement SystemSold 4,146 shares on 5/16/2024Ownership: 0.084%Price T Rowe Associates Inc. MDBought 11,174 shares on 5/15/2024Ownership: 0.045%View All Insider TransactionsView All Institutional Transactions DCGO Stock Analysis - Frequently Asked Questions Should I buy or sell DocGo stock right now? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DocGo in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" DCGO shares. View DCGO analyst ratings or view top-rated stocks. What is DocGo's stock price target for 2024? 5 Wall Street analysts have issued twelve-month price objectives for DocGo's shares. Their DCGO share price targets range from $5.00 to $16.00. On average, they expect the company's stock price to reach $7.75 in the next year. This suggests a possible upside of 154.1% from the stock's current price. View analysts price targets for DCGO or view top-rated stocks among Wall Street analysts. How have DCGO shares performed in 2024? DocGo's stock was trading at $5.59 at the beginning of 2024. Since then, DCGO stock has decreased by 45.4% and is now trading at $3.05. View the best growth stocks for 2024 here. When is DocGo's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 5th 2024. View our DCGO earnings forecast. How were DocGo's earnings last quarter? DocGo Inc. (NASDAQ:DCGO) issued its earnings results on Wednesday, February, 28th. The company reported $0.06 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.13 by $0.07. The company earned $199.25 million during the quarter, compared to analysts' expectations of $195.48 million. DocGo had a trailing twelve-month return on equity of 6.20% and a net margin of 2.98%. What ETF holds DocGo's stock? Global X Telemedicine & Digital Health ETF holds 60,434 shares of DCGO stock, representing 0.37% of its portfolio. What guidance has DocGo issued on next quarter's earnings? DocGo issued an update on its FY 2024 earnings guidance on Wednesday, May, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $600.0 million-$650.0 million, compared to the consensus revenue estimate of $714.3 million. Who are DocGo's major shareholders? DocGo's stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (4.66%), WCM Investment Management LLC (2.52%), Kennedy Capital Management LLC (1.42%), Isthmus Partners LLC (0.58%), Pasadena Private Wealth LLC (0.38%) and Janus Henderson Group PLC (0.33%). Insiders that own company stock include Adriaan Stephanus Oberholzer, Anthony Capone, Ely D Tendler, James M Travers, Lee Bienstock, Michael J Burdiek and Stephen Sugrue. View institutional ownership trends. How do I buy shares of DocGo? Shares of DCGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:DCGO) was last updated on 5/27/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsTop 5 AI Stocks to Buy for 2024Market Moving TrendsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsMan who spotted Apple at $1.49 says: “Buy These 6 AI Stocks.”InvestorPlaceWARNING about the death of the U.S. dollar…Colonial MetalsTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DocGo Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.